# Trial of Decitabine in Patients With Acute Myeloid Leukemia

> **NCT00260832** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 485 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Cytarabine or Supportive Care
- **DRUG:** Dacogen (decitabine) only

## Key facts

- **NCT ID:** NCT00260832
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2009-10
- **Final completion:** 2010-12
- **Target enrollment:** 485 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260832, "Trial of Decitabine in Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00260832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*